YS Biopharma

closedW=S@11.50
YSSEC EDGARCIK: 0001946399|YS Biopharma•Biopharmaceutical

Capital Structure & Economics

Trust SizeN/A
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Public Trust AllocationN/A
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedApr 12, 2023
SearchingTarget Pending
Maturation Wall
Mar 16, 2023

Announced Target / M&A

  • Target CompanyYS Biopharma
  • SectorBiopharmaceutical

Board & Officers

  • Dr. Hui ShaoCEO
  • Yi ZhangDirector
  • Mr. Bo TanDirector
  • Dr. Ajit ShettyDirector
  • Dr. Viren MehtaDirector
  • Dr. Stanley Yi ChangDirector
  • Mr. Shaojing TongDirector
  • Dr. Zenaida Reynoso MojaresDirector
  • Ms. Chunyuan WuDirector
  • Dr. Yuan LiuDirector
  • Mr. Gang LiDirector
  • Bo Tan(2)
    Director
  • Ken Poon(3)
    Director
  • Ian Stone(2)
    Director
  • Thomas Folinsbee(3)
    Director
  • Tao Bai(2)
    Director

Advanced Structuring Terms

Target SectorsBiopharmaceutical

Syndicate & Advisors

  • Wei, Wei & Co., LLPAUDITOR
  • Jingtian & GongchengCOUNSEL ISSUER
  • Snow Lake Capital (HK) LimitedPIPE PLACEMENT AGENT
  • Valliance FundPIPE PLACEMENT AGENT

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction